Earnings Management and Valuation of Biological Assets

The use of fair value to measure the worth of biological assets allows discretionary choices when using discounted cash flow in the absence of an active market, influencing the quality of accounting information. The objective of this study was to investigate evidence of earnings management among Br...

Full description

Saved in:
Bibliographic Details
Main Authors: Ricardo Luiz Menezes da Silva, Paula Carolina Ciampaglia Nardi, Maisa de Souza Ribeiro
Format: Article
Language:English
Published: FUCAPE Business School 2015-01-01
Series:BBR: Brazilian Business Review
Subjects:
Online Access:http://www.redalyc.org/articulo.oa?id=123041058001
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825207381926084608
author Ricardo Luiz Menezes da Silva
Paula Carolina Ciampaglia Nardi
Maisa de Souza Ribeiro
author_facet Ricardo Luiz Menezes da Silva
Paula Carolina Ciampaglia Nardi
Maisa de Souza Ribeiro
author_sort Ricardo Luiz Menezes da Silva
collection DOAJ
description The use of fair value to measure the worth of biological assets allows discretionary choices when using discounted cash flow in the absence of an active market, influencing the quality of accounting information. The objective of this study was to investigate evidence of earnings management among Brazilian companies that have adopted fair value based on the discounted cash flow method. The firms were investigated with regard to: a) disclosure of the discount rate, b) BM&FBovespa corporate governance levels; and c) adherence to disclosure requirements in the Brazilian accounting standard CPC 29 (IAS 41). We analyzed 31 firms with significant biological assets from 2010 to 2012. The earnings management measurements were calculated according to the modified Jones, the Teoh, Welch and Wong (1998), and the KS models. The Mann-Whitney test of the means was applied and revealed evidence of greater earnings management for companies that use discounted cash flow, and the ones that least meet CPC 29 disclosure requirements, considering the KS model estimates. Regarding the other proposals, testing did not offer enough evidence of differences in discretionary accruals. In this sense, only hypotheses 1 and 4 are partially accepted, demanding more research in this area. We also present evidence in favor of adopting Exposure Draft ED/2013/08 Agriculture: Bearer Plants, Proposed amendments to IAS 16 and IAS 41, which proposes to measure biological assets at cost, because firms already following these rules showed lower earnings management in this study.
format Article
id doaj-art-e8939d8f798f45ef815b1220de957b9e
institution Kabale University
issn 1807-734X
language English
publishDate 2015-01-01
publisher FUCAPE Business School
record_format Article
series BBR: Brazilian Business Review
spelling doaj-art-e8939d8f798f45ef815b1220de957b9e2025-02-06T23:39:31ZengFUCAPE Business SchoolBBR: Brazilian Business Review1807-734X2015-01-01124126Earnings Management and Valuation of Biological AssetsRicardo Luiz Menezes da SilvaPaula Carolina Ciampaglia NardiMaisa de Souza RibeiroThe use of fair value to measure the worth of biological assets allows discretionary choices when using discounted cash flow in the absence of an active market, influencing the quality of accounting information. The objective of this study was to investigate evidence of earnings management among Brazilian companies that have adopted fair value based on the discounted cash flow method. The firms were investigated with regard to: a) disclosure of the discount rate, b) BM&FBovespa corporate governance levels; and c) adherence to disclosure requirements in the Brazilian accounting standard CPC 29 (IAS 41). We analyzed 31 firms with significant biological assets from 2010 to 2012. The earnings management measurements were calculated according to the modified Jones, the Teoh, Welch and Wong (1998), and the KS models. The Mann-Whitney test of the means was applied and revealed evidence of greater earnings management for companies that use discounted cash flow, and the ones that least meet CPC 29 disclosure requirements, considering the KS model estimates. Regarding the other proposals, testing did not offer enough evidence of differences in discretionary accruals. In this sense, only hypotheses 1 and 4 are partially accepted, demanding more research in this area. We also present evidence in favor of adopting Exposure Draft ED/2013/08 Agriculture: Bearer Plants, Proposed amendments to IAS 16 and IAS 41, which proposes to measure biological assets at cost, because firms already following these rules showed lower earnings management in this study.http://www.redalyc.org/articulo.oa?id=123041058001earnings managementbiological assetsagricultural productsfair valueias 41
spellingShingle Ricardo Luiz Menezes da Silva
Paula Carolina Ciampaglia Nardi
Maisa de Souza Ribeiro
Earnings Management and Valuation of Biological Assets
BBR: Brazilian Business Review
earnings management
biological assets
agricultural products
fair value
ias 41
title Earnings Management and Valuation of Biological Assets
title_full Earnings Management and Valuation of Biological Assets
title_fullStr Earnings Management and Valuation of Biological Assets
title_full_unstemmed Earnings Management and Valuation of Biological Assets
title_short Earnings Management and Valuation of Biological Assets
title_sort earnings management and valuation of biological assets
topic earnings management
biological assets
agricultural products
fair value
ias 41
url http://www.redalyc.org/articulo.oa?id=123041058001
work_keys_str_mv AT ricardoluizmenezesdasilva earningsmanagementandvaluationofbiologicalassets
AT paulacarolinaciampaglianardi earningsmanagementandvaluationofbiologicalassets
AT maisadesouzaribeiro earningsmanagementandvaluationofbiologicalassets